IVERIC bio ISEE
$ 39.95
0.0%
Quarterly report 2023-Q1
added 05-10-2023
Country |
USA |
IPO year |
2013 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Mr. Glenn Sblendorio |
Employees in the company |
55 |
Shares |
121 M |
Market Cap[1] |
$ 5.51 B |
EBITDA (LTM) |
$ -175 M |
P/E (LTM) |
-26.57 |
P/S (LTM) |
- |
EPS (LTM) |
-1.4 |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.